resorbable (rēsor´bəbəl),

adj that which can be broken down and assimilated back into the body.
References in periodicals archive ?
July 20, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has initiated a study of the company's first fully resorbable drug-eluting scaffold system.
However, the resorbable fixators segment is expected to expand at the highest CAGR due to high reabsorption power in approximately 12 months and greater biocompatibility.
The UAE is the first country in the region to use the new generation GT 1 Bi- Resorbable Scaffold (BVS) Systems that dissolve within three years, leaving the artery clear.
which makes biomaterials, has introduced Proxy Bio-XT, a strength-reinforcing technology for resorbable orthopedic products.
Herein we share our experience with resorbable poly (D,L) lactic acid (PDLLA) mesh fixed with ultrasound-activated pins to secure the cochlear implant receivers to the temporoparietal skull.
MPC uses special polyester resins to mold resorbable devices.
Oceanport, NJ) has been issued United States Patent 6,579,951 from the United States Patent and Trademark Office covering novel resorbable polymeric materials exhibiting reverse thermal gelation properties which may be used in a variety of biomedical product applications including implantable drug and cell delivery, gene therapy, sealants as well as in the company's main focus of post-operative adhesion prevention products.
VITOSS is a resorbable calcium phosphate scaffold that is highly porous and composed of extremely fine calcium phosphate mineral that allows for resorption, cell seeding and ingrowth of host bone.
Medisse is active in resorbable implants for soft tissue applications, based on a patented flexible polymer platform.
Contract notice: upply of neurosurgical implants and resorbable and titanium clips used in neurochiorurgii for the department of neurosurgery institute czmp.
CoSeal is a resorbable synthetic sealant for use in sealing vascular grafts.
DESolve[TM]: Fully resorbable vascular scaffold currently in follow-up phase of the CE Mark trial